Transgenics to Be a $12 Billion Market by 2012

Kalorama analysts expect transgenics to become a $12 billion market by 2012. The first drug approvals using transgenics are expected this year, resulting in a $225 million market. Read about this new report.

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments